logo-loader
RNS
Ophir Energy Plc

Statement re Court Meeting

/**/ h1{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}h2{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}h3{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}h4{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}h5{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}h6{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #AF005F }visited{ color: #AF005F } .eo{size:21.0cm 841.95pt;margin:3.0cm 79.4pt 65.2pt 79.4pt;}div.eo{}p.fv{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold}p.fw{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; text-align: center}p.fx{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:12.5pt;font-family:"Arial","sans-serif";font-weight:bold;text-align: center}span.fr{font-size:10.0pt;line-height:120%}p.fy{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:12.5pt;font-family:"Arial","sans-serif";font-weight:bold;text-align: right}span.fp{font-size: 10.0pt;line-height:120%}p.ac,li.ac,div.ac{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";}span.fn{line-height: 120%} span.fm{line-height:120%}p.fz{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;font-size:10.5pt;font-family:"Arial","sans-serif";font-weight:bold;margin-bottom:0cm;margin-bottom:.0001pt;line-height: 150%}span.fl{font-size:10.0pt;line-height:150%}table.ga{width:444.85pt;margin-left:-5.4pt;border-collapse:collapse}td.fi{width:292.3pt;padding:0cm 5.4pt 0cm 5.4pt}p.gb{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;text-align:justify;font-size:10.0pt;font-family:"Arial","sans-serif";margin-bottom:4.0pt}td.fg{width:130.95pt;padding:0cm 5.4pt 0cm 5.4pt}p.gc{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;text-align:justify;font-size:10.0pt;font-family:"Arial","sans-serif";margin-bottom: 4.0pt; text-align: right}p.gd{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;line-height:150%}span.fe{font-size:10.0pt; line-height:150%;font-family:"Arial","sans-serif"} span.fd{font-size:10.0pt;line-height:150%;font-family:"Arial","sans-serif"; color:windowtext}table.ge{margin-left:-5.4pt;border-collapse:collapse}tr.ew{height:27.9pt}td.ez{width:297.25pt;padding:0cm 5.4pt 0cm 5.4pt; height:27.9pt}p.gf{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold; line-height: 150%}span.fb{font-size:10.0pt; line-height:150%;font-family:"Arial","sans-serif";color:windowtext}td.ex{width:143.25pt;padding:0cm 5.4pt 0cm 5.4pt; height:27.9pt}p.gg{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;text-align:justify;font-size:10.0pt;font-family:"Arial","sans-serif";margin-bottom: 4.0pt; text-align: center}td.eu{width:297.25pt;padding:0cm 5.4pt 0cm 5.4pt}td.et{width:143.25pt;padding:0cm 5.4pt 0cm 5.4pt} p.gh{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic; font-weight: bold}p.gi{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic}p.gj{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:34.0pt;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic; margin-left: 0cm}p.gk{margin-top:0cm;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic; font-weight: bold; page-break-after: avoid} /**/
RNS Number : 4425Z
Ophir Energy Plc
17 May 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

17 May 2019

 

Recommended cash offer

for

Ophir Energy plc ("Ophir")

by

Medco Energi Global PTE Ltd ("Medco Global")

(a wholly-owned subsidiary of PT Medco Energi Internasional Tbk) ("Medco"))

 

Update on Scheme and Timetable

Further to the announcement made by the boards of Ophir, Medco Global and Medco on 9 May 2019, Ophir announces that the Scheme Court Hearing seeking an Order of the Court to sanction the Scheme was held today and a judgment is expected next week. An updated timetable of principal events for completion of the Acquisition and the Scheme will be announced in due course.

Defined terms used but not defined in this announcement have the meanings set out in the scheme document dated 1 March 2019 (the "Scheme Document").

Enquiries

Ophir

Alan Booth / Tony Rouse / Dato Sandroshvili / Geoff Callow

 

+ 44 (0) 20 7811 2400

Morgan Stanley - Lead Financial Adviser and Corporate Broker to Ophir

Andrew Foster / Shirav Patel / Mutlu Guner

 

Lambert Energy Advisory - Financial Adviser to Ophir

Philip Lambert / David Anderson

 +44 (0) 20 7425 8000

 

 

+44 (0) 20 7491 4473

 

Investec - Corporate Broker to Ophir

Chris Sim / Jonathan Wolf

 

+44 (0) 20 7597 4000

Brunswick - Public Relations Adviser to Ophir

Patrick Handley

+44 (0) 20 7404 5959

About Ophir

Ophir is an independent upstream oil and gas exploration and production company. It is listed on the London Stock Exchange (LEI: 213800LAZOZTKPAV2583).

Important notices

Morgan Stanley & Co. International plc ("Morgan Stanley") which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK is acting as financial adviser exclusively for Ophir and no one else in connection with the matters set out in this announcement. In connection with such matters, Morgan Stanley, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in connection with the contents of this announcement or any other matter referred to herein.

Lambert Energy Advisory Limited ("Lambert Energy Advisory"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Ophir and no-one else in connection with the Acquisition and will not be responsible to anyone other than Ophir for providing the protections afforded to clients of Lambert Energy Advisory nor for providing advice in relation to the Acquisition or any other matters referred to in this announcement.

Investec Bank plc ("Investec") which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority is acting exclusively for Ophir and no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Ophir for providing the protections afforded to clients of Investec nor for giving advice in relation to the subject matter of this announcement or any other matter or arrangement referred to in this announcement.

This announcement is for information purposes only and does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities, pursuant to the Acquisition or otherwise. The Acquisition will be made solely by means of the Scheme Document or any document by which the Acquisition is made which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition.

This announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

Overseas shareholders

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements.

Unless otherwise determined by Medco or Medco Global or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition shall be not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Acquisition by any such use, means, instrumentality or form within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this announcement and all documents relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction where to do so would violate the laws in that jurisdiction.

Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction and, to the fullest extent permitted by applicable law, Ophir, Medco and Medco Global disclaim any responsibility or liability for the violation of such restrictions by any person.

The availability of the Acquisition to Ophir Shareholders who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements.

Disclosure requirements of the Takeover Code (the "Code")

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

Publication on website

A copy of this announcement will be made available on Ophir's website at www.ophir-energy.com/information-re-recommended-firm-cash-offer/ and Medco's website at www.medcoenergi.com by no later than 12 noon (London time) on the business day following the date of this announcement. For the avoidance of doubt, the contents of these wesbites are not incorporated into and do not form part of this announcement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FURSFFFEWFUSEFI

Quick facts: Ophir Energy Plc

Price: £0.00

Market: LSE
Market Cap: £0.00
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE